First Trust Nasdaq Pharmaceuticals ETF (FTXH): ETF
ETF traded on XNAS under symbol FTXH. Quoted in usd.
First Trust Nasdaq Pharmaceuticals ETF
+0.69%$43.43
XNAS:FTXHSector Equity
AUM $1.18B·YTD --·Yield --
XNAS:FTXH$43.43+0.69%AUM $1.18BTop Holdings
56.1% of portfolio in top 10 holdings
Concentrated in Healthcare (100.0%)
Performance:
 | LLY Eli Lilly and Company | +16.98% | 69.7K | |
 | ABBV AbbVie Inc. | +9.23% | 314.5K | |
 | JNJ Johnson & Johnson | +8.42% | 303.3K | |
 | PFE Pfizer Inc. | +6.87% | 2.83M | |
 | MRK Merck & Co., Inc. | +3.37% | 545.7K | |
 | VTRS Viatris Inc. | +13.51% | 2.44M | |
 | BIIB Biogen Inc. | +11.42% | 186.1K | |
 | GILD Gilead Sciences, Inc. | +15.71% | 275.5K | |
 | REGN Regeneron Pharmaceuticals, Inc. | +22.42% | 50.5K | |
 | AMGN Amgen Inc. | +14.36% | 93.8K | |
 | ZTS Zoetis Inc. | +11.31% | 522.9K | |
 | VRTX Vertex Pharmaceuticals Incorporated | +8.91% | 74.0K | |
 | UTHR United Therapeutics Corporation | +3.77% | 70.1K | |
 | INCY Incyte Corporation | +6.14% | 323.5K | |
 | BMY Bristol-Myers Squibb Company | +4.28% | 603.4K | |
 | EXEL Exelixis, Inc. | +19.27% | 449.1K | |
 | JAZZ Jazz Pharmaceuticals Plc | +1.46% | 128.2K | |
 | ILMN Illumina, Inc. | -22.08% | 93.1K | |
 | MEDP Medpace Holdings, Inc. | +8.33% | 27.8K | |
 | HALO Halozyme Therapeutics, Inc. | -5.55% | 161.9K | |
 | NBIX Neurocrine Biosciences, Inc. | +13.14% | 95.3K | |
 | ELAN Elanco Animal Health Incorporated | +14.50% | 578.3K | |
 | BMRN BioMarin Pharmaceutical Inc. | -0.34% | 236.1K | |
 | CRL Charles River Laboratories International, Inc. | +10.68% | 39.0K | |
 | MRNA Moderna, Inc. | +35.60% | 39.9K |
Institutional Holders
Sector Breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.00% |
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 99.49% |
| United Kingdom | 0.51% |